Zobrazeno 1 - 10
of 117
pro vyhledávání: '"C, Donada"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gastone Zanette, A Pizziol, V. Donadon, Valérie Tikhonoff, C. Donada, Alberto Mazza, Edoardo Casiglia, Paolo Palatini, Ac Pessina
Publikováno v:
European Journal of Epidemiology. 16:677-684
Although non-insulin-dependent diabetes mellitus (NIDDM) is considered a major cause of death, the role of some independent risk factors in diabetic patients is under debate. In fact the prognosis of NIDDM diabetes varies considerably in relation to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf8fb66ec6825f19ce392af06f392cfb
https://doi.org/10.1023/a:1007673123716
https://doi.org/10.1023/a:1007673123716
Autor:
Alessandra Viel, A Zarrelli, M. Boiocchi, Giuseppe Corona, M. Fabris, Giuseppe Toffoli, C Donada
Publikováno v:
European Journal of Cancer. 33:1284-1290
The major role of the high-affinity folate-binding protein (FBP) is to regulate cellular folate homeostasis by increasing folate uptake in case of extracellular and intracellular folate deficiency. On this basis, we hypothesised that the overexpressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92428b90b136c3c77cf2a18d0288a03
https://doi.org/10.1016/s0959-8049(97)00121-4
https://doi.org/10.1016/s0959-8049(97)00121-4
Autor:
G. F. SANTINI, F. GIANNINI, M. CROVATTO, S. CESELLI, MAZZARO, C. DONADA, G. MAZZI, S. SULFARO, M. ROMANELLI, S. CHIAROTTO, F. INVERNIZZI, POZZATO, GABRIELE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8d26f44971679121e63a4fca47ce3348
http://hdl.handle.net/11368/1699564
http://hdl.handle.net/11368/1699564
Autor:
A. ALBERTI, L. CHEMELLO, P. BONETTI, C. CASARIN, G. DIODATI, L. CAVALLETTO, M. FREZZA, C. DONADA, F. BELUSSI, P. CASARIN, A. RUOL AND THE TVVH STUDY GROUP, POZZATO, GABRIELE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___01099::06f9a8a923e9b4b1f83c83917f394273
https://hdl.handle.net/11368/1699582
https://hdl.handle.net/11368/1699582
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
L, Cavalletto, L, Chemello, C, Donada, P, Casarin, F, Belussi, E, Bernardinello, F, Marino, P, Pontisso, A, Gatta, A, Alberti
In chronic hepatitis C, interferon-alpha (alpha-IFN) and ribavirin combination therapy improves sustained response compared to alpha-IFN monotherapy, both in naive patients and in previous alpha-IFN relapsers, but the efficacy of such therapy remains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d32d41295b3bc51a33bcbd731cfcf671
http://hdl.handle.net/11577/2518123
http://hdl.handle.net/11577/2518123
Autor:
E, Casiglia, G, Zanette, A, Mazza, V, Donadon, C, Donada, A, Pizziol, V, Tikhonoff, P, Palatini, A C, Pessina
Although non-insulin-dependent diabetes mellitus (NIDDM) is considered a major cause of death, the role of some independent risk factors in diabetic patients is under debate. In fact the prognosis of NIDDM diabetes varies considerably in relation to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::929d6fe01891968f8ead58110f83fe3f
http://hdl.handle.net/11577/2456013
http://hdl.handle.net/11577/2456013
Autor:
Cesare Mazzaro, Armando Gabrielli, S. De Vita, Davide Filippini, A.M. Baragiotta, A. Tellan, C. Donada, Gabriele Pozzato, Giuseppe Monti
Publikováno v:
Digestive and Liver Disease. 40:A24-A25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7403e886b2b7f795dc73df7c8c4e5e10
https://doi.org/10.1016/j.dld.2007.12.068
https://doi.org/10.1016/j.dld.2007.12.068
Autor:
E, Bernardinello, L, Cavalletto, L, Chemello, I, Mezzocolli, C, Donada, L, Benvegnú, C, Merkel, A, Gatta, A, Alberti
Few data are available concerning the short and long-term effects of beta-IFN in patients with chronic hepatitis C.We randomized 61 consecutive patients with HCV-related cirrhosis to receive: a) natural beta-IFN with a 6 MU/tiw for 6 months followed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dc30a2bf23abc19294f7f9d378def9a0
http://hdl.handle.net/11577/2471984
http://hdl.handle.net/11577/2471984